As such, tumour angiogenesis in mice can be abrogated through systemic administration of an anti-S1P antibody [104], or through down-regulation of the S1P1 receptor, which is essential for the angiogenic properties of S1P [68,130]. The gene discussed is MBTPS1; the disease is neoplasm.